- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips, Siemens land VA contract
Philips, Siemens land VA contractIn a move that brought two major multimodality vendors into collaboration, the Veterans Affairs Acquisition Center this month awarded Siemens Medical Systems and Philips Medical Systems North America a joint
Philips, Siemens land VA contract
In a move that brought two major multimodality vendors into collaboration, the Veterans Affairs Acquisition Center this month awarded Siemens Medical Systems and Philips Medical Systems North America a joint contract to provide computed radiography equipment and related connectivity services to seven VA hospitals. The $7 million contract is part of the Veterans Integrated Network System project, which includes six southern California VA hospitals and one in Las Vegas.
Iselin, NJ-based Siemens will supply image review workstations and archive servers with database management. Shelton, CT-based Philips will provide CR equipment, including RIS interfaces, as well as film digitizers and printing capabilities. The two firms expect the systems to be installed by the end of this month.
- Search again
- Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
